Literature DB >> 2390525

Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in Graves' ophthalmopathy.

S E Feldon1, L Levin.   

Abstract

The volume of the levator superior rectus muscle complex was determined from computed tomography scans of 152 orbits from 76 patients with Graves' ophthalmopathy. Clinically observed lid retraction and lid lag did not correlate with the levator/superior rectus muscle volume and did not correlate with limitation of vertical eye movements or inferior rectus muscle volume. These results do not support previously published hypotheses that muscle hypertrophy or levator/superior rectus muscle overaction secondary to inferior rectus muscle restriction are major causes of lid retraction and lid lag. Local adhesion of the levator muscle to fixed orbital tissues is postulated to be the most likely basis for the characteristic lid retraction and lid lag of Graves' ophthalmopathy.

Entities:  

Mesh:

Year:  1990        PMID: 2390525      PMCID: PMC1042179          DOI: 10.1136/bjo.74.8.484

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Graves' ophthalmopathy: II. Correlation of clinical signs with measures derived from computed tomography.

Authors:  E S Hallin; S E Feldon
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

2.  Lid retraction and levator aponeurosis defects in Graves' eye disease.

Authors:  B R Frueh; D C Musch; F W Garber
Journal:  Ophthalmic Surg       Date:  1986-04

3.  Surgical treatment of upper eyelid retraction.

Authors:  A M Putterman; M Urist
Journal:  Arch Ophthalmol       Date:  1972-04

4.  Clinical significance of extraocular muscle volumes in Graves' ophthalmopathy: a quantitative computed tomography study.

Authors:  S E Feldon; J M Weiner
Journal:  Arch Ophthalmol       Date:  1982-08

5.  Upper eyelid retraction and Graves' disease.

Authors:  A S Grove
Journal:  Ophthalmology       Date:  1981-06       Impact factor: 12.079

6.  Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy.

Authors:  A J Kroll; T Kuwabara
Journal:  Arch Ophthalmol       Date:  1966-08

7.  Enlargement of levator palpebrae superioris muscle fibers in Graves' ophthalmopathy.

Authors:  R G Small
Journal:  Ophthalmology       Date:  1989-04       Impact factor: 12.079

  7 in total
  6 in total

1.  Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy.

Authors:  J R Wall; H Triller; A Boucher; N F Bernard; M Salvi; M Ludgate
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

2.  Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.

Authors:  Jun Soo Byun; Jeong Kyu Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-29       Impact factor: 3.117

3.  The graded levator hinge procedure for the correction of upper eyelid retraction (an American Ophthalmological Society thesis).

Authors:  Daniel P Schaefer
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 4.  Clinical Pearls and Management Recommendations for Strabismus due to Thyroid Orbitopathy.

Authors:  Elham S Al Qahtani; Jack Rootman; James Kersey; Flavia Godoy; Christopher J Lyons
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jul-Sep

5.  Serum Selenium Levels in Patients with Graves Disease: Associations with Clinical Activity and Severity in a Retrospective Case-control Study.

Authors:  Tae Hwan Kim; JaeSang Ko; Bo Ram Kim; Dong Yeob Shin; Eun Jig Lee; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2021-11-08

6.  Correlation between Extraocular Muscle Size Measured by Computed Tomography and the Vertical Angle of Deviation in Thyroid Eye Disease.

Authors:  Ju-Yeun Lee; Kunho Bae; Kyung-Ah Park; In Jeong Lyu; Sei Yeul Oh
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.